Stanford scientists discovered that a harmless skin bacterium triggers a powerful immune response. By tweaking a bacterial ...

Local companies are developing technologies that they hope could replace a painful poke with something that feels more like ...

The grit and determination of Real Madrid's Federico Valverde was evidenced during the Champions League clash with Manchester ...

The patch-delivered vaccine trial received $28.5m in funding from US authorities as a potential pandemic preparation.

This study demonstrated that 32-G 5-mm needles can be reliably inserted into subcutaneous fat, are relatively pain free, and are associated with minimal leakage from the injection site.

Vaxxas’ proprietary high-density microarray patch (HD-MAP) technology is currently being evaluated in a phase 1 clinical study of the first needle-free COVID-19 vaccine, having demonstrated ...

The 19-year-old student reported the incident to the police that weekend after a hospital visit confirmed a bruise on his arm ...

The Nigeria study results show how using Tropis for routine immunization can provide significant benefits at all levels of the healthcare system..